Combined detection of P53, Ki67, P504S, and IMP3: Diagnostic implications for gastric cancer and precursor lesions

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

253

Figures (1-4)

Tables (1-3)

Sum=452

Publishing Process of This Article

Item

Count

Browse

Download

Sum=97

May 15, 2025 (publication date) through Jun 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. May 15, 2025; 17(5): 105604
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105604

Table 3 Sensitivity and specificity of P53, IMP3, and their combination for diagnosing high-grade dysplasia/adenocarcinoma

¹P53 and IMP3 are used in parallel for the combined diagnosis of high-grade dysplasia/adenocarcinoma.

AH: Atypical hyperplasia; LGD: Low-grade dysplasia; HGD: High-grade dysplasia; AC: Adenocarcinoma.

Citation: Miao LF, Sun YY, Du XJ, Xu N, Shen JW, Hua H, Guo M, Yang HJ, Li JK, Zhu L. Combined detection of P53, Ki67, P504S, and IMP3: Diagnostic implications for gastric cancer and precursor lesions. World J Gastrointest Oncol 2025; 17(5): 105604
URL: https://www.wjgnet.com/1948-5204/full/v17/i5/105604.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.105604